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DObjective: Clinical echocardiographic assessments of the Medtronic ADVANTAGE (Medtronic Inc, Minneap-
olis, Minn) prosthesis in the aortic position revealed a phenomenon identified as ‘‘intermittent regurgitation.’’ An
in vitro investigation was initiated to identify the underlying mechanism.
Methods: In a pulse duplicator environment, 6 ADVANTAGE size 23 aortic valves were analyzed. Leaflet mo-
tion and flow through the valves were documented using echocardiography with color Doppler flow, digital high
speed imaging, and flow meter assessment.
Results: Intermittent regurgitation could be reproduced in all 6 of the tested valves within limited ranges of flow,
pressure, and valve orientation. By virtue of high-speed imaging, the mechanism underlying intermittent regur-
gitation was identified. During intermittent regurgitation, the leading edge of the second-to-close leaflet makes
contact with the chamfer on the leading edge of the first-to-close leaflet. The fluid closing forces working on
the first-to-close leaflet prevent it from shifting back so that the leading edge of the second-to-close leaflet remains
positioned against the chamfer of the first-to-close leaflet. In this position, the major radius of the second-to-close
leaflet does not reach the housing’s major radius. Therefore, a crescent-shaped gap remains between the leaflet tip
of the second-to-close leaflet and the housing major radius during all or part of diastole. The regurgitant fraction
can increase from a normal range of 6% to 25% during an intermittent regurgitation beat.
Conclusions: In vitro intermittent regurgitation can be induced in the size 23 aortic ADVANTAGE valve under
a limited range of conditions. To avoid possible misinterpretations, the phenomenon must be known in detail by
all physicians dealing with patients with an ADVANTAGE valve. (J Thorac Cardiovasc Surg 2010;140:611-6)In 2006 the first report1,2 was published of a phenomenon
identified as ‘‘intermittent regurgitation’’ (IR), which oc-
curred after implantation of a Medtronic ADVANTAGE
(Medtronic Inc, Minneapolis, Minn) bileaflet heart valve
prosthesis in the aortic position. Since then, 3 reoperations
have been performed in different centers in patients whose
aortic valve prosthesis showed IR only because the phenom-
enon had been misinterpreted as potential valve thrombosis.3
After learning of the first 2 reoperations, Medtronic Inc, the
manufacturer of the ADVANTAGE valve, communicated
the IR phenomenon worldwide to implanters of the ADVAN-e German Heart Center Munich, Department of Cardiovascular Surgery,
ch, Germany.
: In vitro measurements were performed by Medtronic Inc, Minneapolis,
esota.
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The Journal of Thoracic and CaTAGE valve. Because the mechanism of IR was not clear, the
German Heart Center Munich and Medtronic Inc initiated an
in vitro investigation to detect the underlying mechanism.
MATERIALS AND METHODS
In Vivo Findings in Patients Presenting With
Intermittent Regurgitation
All bileaflet mechanical valves exhibit some minor regurgitation at the
pivot points.4 The pivot region is designed to allow washing jets to reduce
the risk of thrombus formation. In circumstances in which the echo windows
are of sufficient quality to permit good diagnostic imaging, this trivial regur-
gitation is seen in every diastole by color Doppler flow imaging as 2 small
jets not exceeding the left ventricular outflow tract, homogeneous in color,
reflecting its low momentum.5
In contrast, the clinical echo findings in IR were intermittent, single-beat,
mild-to-moderate regurgitant jets during diastole. Those jets were different
in extension and grade of insufficiency compared with the expected washing
jets in bileaflet valves. The phenomenon appeared in irregular intervals and
was reproducible in most of the consecutive echo investigations performed
on individual patients.
Fluoroscopy of the patients who exhibited echocardiographic signs of IR
revealed intermittent incomplete closure of the valve leaflets, which could in-
volve either 1 of the 2 leaflets in the same prosthesis. Simultaneous direct blood
pressure measurement in the ascending aorta approximately 2 cm distally to
the prosthesis showed a diastolic pressure decrease during each IR beat.1,2
Medtronic ADVANTAGE Prosthetic Heart Valve
The Medtronic ADVANTAGE prosthesis is a bileaflet mechanical heart
valve. The design consists of 2 pyrolytic carbon-coated leaflets constrainedrdiovascular Surgery c Volume 140, Number 3 611
Abbreviation and Acronym
IR ¼ intermittent regurgitation
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Dwithin a pyrolytic carbon-coated housing. A rotatable, fabric sewing ring is af-
fixed to the valve by a titanium insert ring that is located below the level of the
carbon housing. A new asymmetric, multilevel butterfly hinge mechanism is
realized in this prosthesis, the leaflet opening angle is 86 degrees, and the clos-
ing angle is 22 degrees. The ADVANTAGE valve has been in clinical use
since 1999 with approximately 11,000 patients receiving implants worldwide
up to the present (Medtronic Inc, personal communication, September 2007).
In Vitro Configuration in a Pulse Duplicator
Six ADVANTAGE size 23 aortic valves were fixed in a pulse duplicator,
which allowed for high-speed imaging, ultrasound examination from the in-
flow aspect of the valve, or simultaneous recording of the flow meter signals
with the electromagnetic flow meter probe in series to the valve. Flow meter
signals were simultaneously recorded on the color Doppler images of the
ultrasound system. The pulse duplicator stroke volume and frequency
were adjusted until the IR phenomena were observed. It was also necessary
to manipulate the valve orientation to produce the IR phenomenon. The
valve was affixed in the hydraulic loop in 4 different orientations to gravity
(Figure 1).
In Vitro Color Doppler Flow Assessment
The color Doppler images were recorded from the inflow side of the
valve using an ultrasound system that is widely used in clinical practice
(General Electric Vivid 7, Waukesha, Wis). This view is comparable to
an in vivo apical view.
High-Speed Imaging
Images of the ADVANTAGE valve during a normal beat closure and an
IR beat closure were obtained with a digital camera running at 1000 frames
per second.RESULTS
Clinical Findings
Since August 2003, echocardiographic assessment re-
vealed IR in 18 reported cases in different centers. IR wasFIGURE 1. A, Horizontal valve axis with vertical leaflets, the rotational axis of
lets, the rotational axis of the leaflets perpendicular to gravity. C, D, Vertical valv
dicular to gravity.
612 The Journal of Thoracic and Cardiovascular Surgdetected in valve sizes 21 to 27: valve size 21 in 2 cases,
valve size 23 in 12 cases, valve size 25 in 2 cases, valve
size 27 in 1 case, and valve size unknown in 1 case (Med-
tronic Inc, personal communication, September 2007).
Three reoperations were performed for suspected valve
thrombosis. During 1 reoperation in a patient presenting
with IR, the valve was left in place after exclusion of valve
thrombosis; after the reoperation, the valve still showed IR.
In another patient, the valve was explanted and replaced by
a bioprosthesis. In the third patient, the ADVANTAGE
valve showing IR was replaced with another ADVANTAGE
valve, which then again showed IR.Color Doppler Assessment
The video images from the in vitro and in vivo color
Doppler examination are shown under normal operation
(Figure 2, A) and in the case of IR (Figure 2, B). Color Dopp-
ler flow shows larger velocities and a larger color-coded area
in IR. The schematic drawings illustrate the typical color
Doppler findings from the valve’s inflow side.High-Speed Imaging of Valve Closure
Asynchronous closing of normal functioning bileaflet
valves is a well-known and documented phenomenon.6
During normal closure, the first-to-close leaflet comes to
a fully closed position. As the tip of the first-to-close leaflet
makes contact with the housing major radius, the leading
edge of the leaflet slides across the midline of the housing
and stops moving. As the second-to-close leaflet moves to-
ward closure, its leading edge makes contact with the lead-
ing edge of the first-to-close leaflet. After contact between
the 2 leaflets, there is a normal rocking (sliding back-and-
forth) that results in the leading edge of the first-to-close
leaflet being shifted back toward the midline. In vitro
high-speed imaging showed that IR occurs when the shift-
ing of the first-to-close leaflet back toward the midline isthe leaflets parallel to gravity. B, Horizontal valve axis with horizontal leaf-
e axis with the inflow side down and up, the leaflets rotational axis perpen-
ery c September 2010
FIGURE 2. A, Jets seen in a normal operation; in vitro echo image (center); in vivo echo with physiologic backflow from an apical view (right). B, Jets in an
IR beat (left), IR in vitro echo image (center), in vivo echo from an apical view (right). Typical IR plume in color Doppler flow imaging (arrow). IR, Inter-
mittent regurgitation.
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makes contact with the chamfer on the leading edge of the
first-to-close leaflet, and the tip of the second-to-close leaf-
let is therefore prevented from coming to rest against the
housing major radius. It stops short of the housing major
radius, and a crescent-shaped gap exists between the leaflet
tip and the housing major radius. Figure 3 illustrates the
mechanism leading to an IR. A complete closure during di-
astole is shown in Figure 4, A, and an incomplete closure is
shown in Figure 4, B.Hydrodynamic Measurements
All 6 of the valves tested exhibited in vitro IR at 68 beats/
min and a cardiac output ranging from 4.0 to 4.5 L/min. One
of the 6 valves was tested at 47 and 95 beats/min with car-
diac output of 2.9 and 5.8 L/min, respectively. Under these
conditions, IR was not detected. In the 7 study patients pre-
senting with IR at the German Heart Center Munich, heart
rates ranged from 45 to 95 beats/min and echocardiograph-
ically determined cardiac outputs ranged from 3.5 to 8.3 L/
min. In vitro, the regurgitant fraction can increase from a nor-The Journal of Thoracic and Camal of 6% to 25% during an IR beat. For the same valve, the
in vitro IR regurgitant volume was not the same every time
the IR event occurred. In vivo, the IR beat regurgitation was
graded mild to moderate.Intermittent Regurgitation Sensitivity to Valve
Orientation in the Gravitational Field
In vitro, the leaflet rotational axis has to be in the horizontal
orientation to reproduce the IR phenomenon. In this orienta-
tion, gravity maximizes asynchronous closure and works
against the closure of the second-to-close leaflet. According
to the different orientations of the valve in the gravitational
field (Figure 1), the frequency of IR events observed varied be-
tween 0% and 6.4% (Figure 1, A, D, 0%; B, 6.4%; C, 5%).Summary of the Results
The in vitro findings showed that IR is caused by a phys-
ical interaction of the leaflets. IR has been replicated in vitro
on every tested ADVANTAGE size 23 aortic valve. Several
factors influencing IR have been elucidated during testing ofrdiovascular Surgery c Volume 140, Number 3 613
FIGURE 3. Leaflets shown in IR position. Gap leading to IR phenomenon
(arrow). IR, Intermittent regurgitation.
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ing the testing.
1. For IR to occur, the leaflet rotational axis has to be in
the horizontal orientation, with the inflow aspect of the
valve oriented either horizontal or down.
2. The frequency of in vitro IR with the size 23 valve
varies from 0% to 6% of the cardiac cycles depending
on the orientation of the valve to gravity.
3. The regurgitant fraction with the size 23 valve in vitro
can increase from a normal of 6% to 25% during an
IR beat.
4. In vitro IR has never resulted in failure of the leaflets
to open.DISCUSSION
There are many reports in the literature dealing with struc-
tural failures of mechanical heart valves affecting both mitralFIGURE 4. A, High-speed imaging of valve closure: Complete valve closure d
Gap leading to IR phenomenon (arrow).
614 The Journal of Thoracic and Cardiovascular Surgand aortic prostheses.7-9 These events are often life-threaten-
ing, and a detailed investigation is necessary if any abnor-
mality is observed in the follow-up of a patient treated
with a mechanical heart valve. Therefore, after the clinical
detection and description of the IR phenomenon,1,2 an in vi-
tro study was initiated to identify the underlying mechanism
and to discern whether the valves that show IR are at an in-
creased risk for structural failure.
IR could be reproduced in all 6 valves that were tested in
the in vitro setting. All tested valves fulfilled the manufac-
turer’s quality specifications. The contact of the leading
edge of the second-to-close leaflet with the chamfer of the
first-to-close leaflet was identified as the underlying mecha-
nism. In vitro, the occurrence of the phenomenon was al-
ways intermittent. An every beat regurgitation could not
be reproduced in the in vitro setting.
An every beat regurgitation case was published in No-
vember 200710: Nine weeks after aortic valve replacement
with an ADVANTAGE prosthesis, the patient returned to
the hospital with new-onset dyspnea. Echocardiographic
evaluation showed an every beat aortic regurgitation grade
II to III with 2 regurgitant jets. During reoperation, in situ
testing showed that the valve insufficiency was caused by
distinct leaflet interference in the valve hinge, which could
be eliminated by applying gentle pressure to the leaflet. The
valve was explanted and returned to the manufacturer for
further investigation. On reexamination of the explant,
the opening angle exceeded 90 degrees and a leaflet overlap
was noticed. Because the valve was functioning normally
in the early postoperative period, wear of the pivot areas
was suspected as the underlying mechanism of valve fail-
ure by the authors. Whether there is any association to
the mechanism causing IR remains unclear.
However, IR has led to 3 reoperations, of which 1 case has
been published.3 This report describes the reoperation of
a patient in which the IR phenomenon was misinterpreted
as a thrombotic obstruction limiting leaflet excursions.uring diastole. B, Incomplete closure of the upper leaflet during an IR beat.
ery c September 2010
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pathologic finding and was left in place. The patient showed
an uneventful postoperative course, but the IR persisted after
the reoperation. In 1 of the other 2 cases of reoperation, the
ADVANTAGE valve was replaced with a bioprosthesis. In
the third case of reoperation, the ADVANTAGE valve was
replaced by another ADVANTAGE valve that then also
showed IR. This suggests that patient-related factors may
contribute to IR. Our assumed patient-related factors are in-
dividual flow and pressure conditions in the aortic root that
prevent the first-to-close leaflet to slip back in a position that
allows the second-to-close leaflet to reach the complete clos-
ing position. These special conditions in the aortic root may
depend on the aortic geometry (angle between left ventricu-
lar outflow tract and ascending aorta, width of the ascending
aorta, and sinuses of Valsalva), blood pressure, peripheral
vessel resistance, heart rhythm and rate, and therefore length
of diastole and end-diastolic left ventricular pressure.
IR in a mechanical valve has also been reported in cases of
nonstructural valve deterioration. In 1 published case, in-
volving another manufacturer’s bileaflet mechanical valve,
subvalvular pannus overgrowth on the inflow aspect of the
prosthesis impeded normal closure of 1 leaflet causing se-
vere aortic regurgitation, which occurred intermittently.11
This case demonstrates again the necessity of a precise iden-
tification of the mechanism causing IR.
The Medtronic ADVANTAGE was implanted in a human
for the first time in 1999. To date, approximately 11,000
ADVANTAGE valves have been implanted in patients
worldwide. To the present, 16 publications deal with the
Medtronic ADVANTAGE prosthesis: Four studies provide
in vitro data,4,12-14 1 animal study is presented,15 1 study fo-
cuses on mitral valve replacement,16 and 10 studies present
human in vivo data concerning the aortic ADVANTAGE
valve.1-3,10,17-22 The IR phenomenon is discussed in only
4 publications.1-3,10 This is partly because IR was unknown
until the first report in March 2006. Because it is not likely
that the IR phenomenon did not exist before 2006, this
shows the difficulty in detecting an event that is character-
ized by its intermittent character. It is most likely that the
standard echo protocol with documentation of color Doppler
loops for only a few cardiac cycles underestimates the actual
incidence of IR because of the intermittent character of the
phenomenon. We hypothesize that the main issue for the de-
tection of IR in vivo is to record long continuous echo loops.
The echocardiographer also should be aware of the typical
color flow pattern of an IR beat to not confuse it with the mi-
tral valve inflow signal or misinterpret IR as a paravalvular
leak or valve thrombosis with permanent obstruction of
the leaflet’s motion.
Two further publications report data for the ADVAN-
TAGE Supra, a modified sewing ring design for complete
supra-annular implantation.23,24 Within the ADVANTAGE
Supra series, the IR phenomenon has not been reported. IRThe Journal of Thoracic and Cahas also not been reported in mitral valves, possibly because
mitral regurgitation in a mechanical valve is covered by the
valve’s shadow in a transthoracic apical view; thus, IR in the
ADVANTAGE mitral valve cannot be completely excluded
by means of transthoracic echo. Even the leakage volume
through the hinge regions is often not clearly identified by
transthoracic echocardiography.5 Alternately, the absence
of reports of IR in the mitral position may be explained by
the larger pressure differential across the mitral valve rela-
tive to the aortic valve. It is possible that the larger pressure
differential provides a sufficient leaflet closing force to over-
come an incomplete closure of a leaflet.
In other clinical studies concerning mechanical valves,25
transvalvular incompetence that exceeded the closing vol-
ume was diagnosed in 2% to 3% of studied valves. This ob-
servation did not lead to reoperation. The most common
reasons for reoperation in mechanical valves are dehiscence,
thrombosis, and pannus in-growth.26
However, 2 major questions remain to be clarified: (1) Is
there any worsening of the long-term hemodynamic and
clinical outcome in patients with ADVANTAGE valves ex-
hibiting IR? (2) Can the IR phenomenon lead to a persistent
dysfunction of valves in the sense of structural valve failure?
In regard to the first question, the manufacturer has reviewed
the records of patients with IR in the ADVANTAGE world-
wide clinical study (n ¼ 12). Their medical records did not
indicate there were different adverse events occurring with
this group, nor was there a higher adverse event rate occur-
ring with this group than with the overall study cohort. In re-
gard to the second question, it should be noted there have
been no reports of leaflet or housing fractures during the
9-year clinical history of the valve. As clinical investigators
for the ADVANTAGE valve, we implanted 84 valves in pa-
tients in the worldwide, multicenter trial. These patients con-
tinue to have satisfactory clinical outcomes as previously
reported.2 We conclude that continued observation of pa-
tients with an ADVANTAGE valve in the aortic position
is warranted, including consecutive echocardiograms to dis-
cern potential hemodynamic or volume loading conse-
quences in the long term with this valve.
CONCLUSIONS
In vitro testing demonstrated IR in every size 23 AD-
VANTAGE valve tested depending on cardiac output and
the valve’s orientation to gravity. Because IR has been re-
ported in multiple ADVANTAGE valve sizes (21, 23, 25,
and 27), we hypothesize that the mechanism underlying IR
elucidated in this article has the potential to cause the IR phe-
nomenon across the spectrum of ADVANTAGE valve sizes.
There are no signs of structural abnormalities in the ex-
planted valves showing IR (Medtronic personal communica-
tion). To avoid further unnecessary reoperations on the
approximately 11,000 patients who have received ADVAN-
TAGE valves worldwide, the phenomenon must be knownrdiovascular Surgery c Volume 140, Number 3 615
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Din detail by all physicians who provide routine medical care
for these patients.
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